Cancer Research Meeting Calendar  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 36, 209-215, January 1, 1976]
© 1976 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Swift, M.
Right arrow Articles by Chase, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Swift, M.
Right arrow Articles by Chase, C.

Malignant Neoplasms in the Families of Patients with Ataxia-Telangiectasia1

Michael Swift2, Laura Sholman, Margery Perry and Charles Chase

Division of Medical Genetics, Department of Medicine and the Biological Sciences Research Center, University of North Carolina, Chapel Hill, North Carolina 27514

Ataxia-telangiectasia (A-T) is an autosomal recessive syndrome associated with a greatly increased incidence of malignant neoplasms in homozygous affected individuals. Heterozygotes for the gene for A-T are thought to comprise about 1% of the general population and, therefore, it is important to know whether this gene also predisposes the heterozygous carrier to cancers. Heterozygous carriers of this gene are common among the close relatives of patients with A-T, although individual carriers cannot be identified by any clinical criterion or laboratory test. For this reason, we compared the incidence of death from malignant neoplasms in 27 families of patients with A-T to that expected in a random sample of the general population.

There were 59 deaths from malignant neoplasms in relatives dying before age 75, compared to 42.6 expected (p < 0.02). For A-T heterozygotes younger than age 45, the risk of dying from a malignant neoplasm was estimated to be greater than 5 times the risk for the general population. A-T heterozygotes may comprise more than 5% of all persons dying from a cancer before age 45.

The incidence of ovarian, gastric, and biliary system carcinomas and of leukemia and lymphoma was increased in these A-T families. Other neoplasms that may be associated with this gene in heterozygotes include pancreatic, basal cell, colonic, breast, and cervical carcinomas.

1 Supported by Grants CA 14235 and HD 03110 from the NIH and PRA 85 from the American Cancer Society.

2 To whom requests for reprints should be addressed.

Received 5/ 9/75. Accepted 10/ 6/75.




This article has been cited by other articles:


Home page
Clin. Cancer Res.Home page
A. Larghi, E. C. Verna, P. G. Lecca, and G. Costamagna
Screening for Pancreatic Cancer in High-Risk Individuals: A Call for Endoscopic Ultrasound
Clin. Cancer Res., March 15, 2009; 15(6): 1907 - 1914.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
M. Swift and J. L. Lukin
Breast Cancer Incidence and the Effect of Cigarette Smoking in Heterozygous Carriers of Mutations in the Ataxia-Telangiectasia Gene
Cancer Epidemiol. Biomarkers Prev., November 1, 2008; 17(11): 3188 - 3192.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
P. Concannon, R. W. Haile, A.-L. Borresen-Dale, B. S. Rosenstein, R. A. Gatti, S. N. Teraoka, A. T. Diep, L. Jansen, D. P. Atencio, B. Langholz, et al.
Variants in the ATM Gene Associated with a Reduced Risk of Contralateral Breast Cancer
Cancer Res., August 15, 2008; 68(16): 6486 - 6491.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Sadetzki, A. Chetrit, A. Lubina, M. Stovall, and I. Novikov
Risk of Thyroid Cancer after Childhood Exposure to Ionizing Radiation for Tinea Capitis
J. Clin. Endocrinol. Metab., December 1, 2006; 91(12): 4798 - 4804.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T.J. Bowen, H. Yakushiji, C. Montagna, S. Jain, T. Ried, and A. Wynshaw-Boris
Atm Heterozygosity Cooperates with Loss of Brca1 to Increase the Severity of Mammary Gland Cancer and Reduce Ductal Branching
Cancer Res., October 1, 2005; 65(19): 8736 - 8746.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y. R. Thorstenson, A. Roxas, R. Kroiss, M. A. Jenkins, K. M. Yu, T. Bachrich, D. Muhr, T. L. Wayne, G. Chu, R. W. Davis, et al.
Contributions of ATM Mutations to Familial Breast and Ovarian Cancer
Cancer Res., June 15, 2003; 63(12): 3325 - 3333.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
T. Dork, R. Bendix, M. Bremer, D. Rades, K. Klopper, M. Nicke, B. Skawran, A. Hector, P. Yamini, D. Steinmann, et al.
Spectrum of ATM Gene Mutations in a Hospital-based Series of Unselected Breast Cancer Patients
Cancer Res., October 1, 2001; 61(20): 7608 - 7615.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
M. Swift
Public Health Burden of Cancer in Ataxia-Telangiectasia Heterozygotes
J Natl Cancer Inst, January 17, 2001; 93(2): 84 - 85.
[Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
J. H. Olsen, J. M. Hahnemann, A.-L. Borresen-Dale, K. Brondum-Nielsen, L. Hammarstrom, R. Kleinerman, H. Kaariainen, T. Lonnqvist, R. Sankila, N. Seersholm, et al.
Cancer in Patients With Ataxia-Telangiectasia and in Their Relatives in the Nordic Countries
J Natl Cancer Inst, January 17, 2001; 93(2): 121 - 127.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
Y. Su and M. Swift
Mortality Rates among Carriers of Ataxia-Telangiectasia Mutant Alleles
Ann Intern Med, November 21, 2000; 133(10): 770 - 778.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
E. R. Fearon
Human Cancer Syndromes: Clues to the Origin and Nature of Cancer
Science, November 7, 1997; 278(5340): 1043 - 1050.
[Abstract] [Full Text]


Home page
ScienceHome page
Y Miki, J Swensen, D Shattuck-Eidens, P. Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L. Bennett, W Ding, et al.
A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1
Science, October 7, 1994; 266(5182): 66 - 71.
[Abstract] [PDF]


Home page
Arch SurgHome page
H. T. Lynch
Genetics and Pancreatic Cancer
Arch Surg, March 1, 1994; 129(3): 266 - 268.
[Abstract] [PDF]


Home page
J Child NeurolHome page
E.O. Chung, J.B. Bodensteiner, P.A. Noorani, and S.S. Schochet Jr
Cerebral White-Matter Changes Suggesting Leukodystrophy in Ataxia Telangiectasia
J Child Neurol, January 1, 1994; 9(1): 31 - 35.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
D. A. LIPSCHITZ, S. GOLDSTEIN, R. REIS, M. E. WEKSLER, R. BRESSLER, and B. A. NEILAN
Cancer in the Elderly: Basic Science and Clinical Aspects
Ann Intern Med, February 1, 1985; 102(2): 218 - 228.
[Abstract] [PDF]


Home page
ANN INTERN MEDHome page
T. A. WALDMANN, J. MISITI, D. L. NELSON, and K. H. KRAEMER
Ataxia-Telangiectasia: A Multisystem Hereditary Disease with Immunodeficiency, Impaired Organ Maturation, X-Ray Hypersensitivity, and a High Incidence of Neoplasia
Ann Intern Med, September 1, 1983; 99(3): 367 - 379.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1976 by the American Association for Cancer Research.